Home » FDA, CancerLinQ to Track Real-World Targeted Therapy Use, Starting With Melanoma Drugs

FDA, CancerLinQ to Track Real-World Targeted Therapy Use, Starting With Melanoma Drugs

Jun 05, 2017
|
Molika Ashford

CHICAGO (GenomeWeb) – The American Society for Clinical Oncology announced this week that it has added two new long-term partners to its big-data initiative CancerLinQ, one of which is the US Food and Drug Administration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Draft Brexit on the Table

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

'Really Just a Titi Monkey'

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

Hold the GMO Mosquitoes

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

This Week in Nature

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.

What's Popular?

In Informatics

  1. Nashville Biosciences Partners With BC Platforms to Offer Biobank Summary Data to Researchers

  2. Hospitals Lagging in Using Discrete Genomics Data for Clinical Decision Support

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.